Literature DB >> 18079075

Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol.

Yeu-Chun Kim1, Jung-Hwan Park, Peter J Ludovice, Mark R Prausnitz.   

Abstract

To develop formulations for transdermal drug delivery, this study tested the hypothesis that the anionic surfactant, N-lauroylsarcosine (NLS), and ethanol synergistically increase skin permeability by increasing the fluidity of stratum corneum lipid structure. Skin permeability experiments showed that transdermal delivery of fluorescein across human cadaver epidermis was increased by up to 47-fold using formulations containing NLS in aqueous ethanol solutions. Skin permeability was increased by increasing NLS concentration in combination with 25-50% ethanol solutions. Skin permeability was shown to correlate with skin electrical conductivity measurements, changes in differential scanning calorimetry lipid transition peak temperature, and Fourier transform infrared spectroscopy CH stretching peak shifts indicative of stratum corneum lipid fluidization and changes in protein conformation. Evidence for lipid extraction was also evident, but did not appear to be responsible for the observed increases in skin permeability. We conclude that NLS in aqueous ethanol formulations can dramatically increase skin permeability by a mechanism involving synergistic lipid-fluidization activity in the stratum corneum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079075     DOI: 10.1016/j.ijpharm.2007.10.031

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Effect of direction (epidermis-to-dermis and dermis-to-epidermis) on the permeation of several chemical compounds through full-thickness skin and stripped skin.

Authors:  Takeshi Oshizaka; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

2.  Investigating transdermal delivery of vitamin D3.

Authors:  Ahmed Alsaqr; Mohammed Rasoully; Florin Marcel Musteata
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

3.  Percutaneous penetration modifiers and formulation effects: thermal and spectral analyses.

Authors:  Diksha Kaushik; Bozena Michniak-Kohn
Journal:  AAPS PharmSciTech       Date:  2010-06-26       Impact factor: 3.246

4.  Mechanism of enhanced dermal permeation of 4-cyanophenol and methyl paraben from saturated aqueous solutions containing both solutes.

Authors:  W J Romonchuk
Journal:  Skin Pharmacol Physiol       Date:  2010       Impact factor: 3.479

5.  Transdermal delivery enhanced by magainin pore-forming peptide.

Authors:  Yeu-Chun Kim; Peter J Ludovice; Mark R Prausnitz
Journal:  J Control Release       Date:  2007-06-02       Impact factor: 9.776

6.  Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax.

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Control Release       Date:  2009-02-06       Impact factor: 9.776

7.  The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane.

Authors:  Michal Stark; Tomás F D Silva; Guy Levin; Miguel Machuqueiro; Yehuda G Assaraf
Journal:  Cells       Date:  2020-04-27       Impact factor: 6.600

8.  Biophysical assessment of DC iontophoresis and current density on transdermal permeation of methotrexate.

Authors:  Rachna Prasad; Sneh Anand; Veena Koul
Journal:  Int J Pharm Investig       Date:  2011-10

9.  Structure Enhancement Relationship of Chemical Penetration Enhancers in Drug Transport across the Stratum Corneum.

Authors:  Doungdaw Chantasart; S Kevin Li
Journal:  Pharmaceutics       Date:  2012-01-17       Impact factor: 6.321

10.  Hyaluronic acid abrogates ethanol-dependent inhibition of collagen biosynthesis in cultured human fibroblasts.

Authors:  Magdalena Donejko; Andrzej Przylipiak; Edyta Rysiak; Wojciech Miltyk; Elżbieta Galicka; Jerzy Przylipiak; Ilona Zaręba; Arkadiusz Surazynski
Journal:  Drug Des Devel Ther       Date:  2015-11-24       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.